Killed virus and bacterin for use in healthy breeding cattle as an aid in the prevention of diseases caused by IBR, PI3, BRSV, cytopathic and noncytopathic BVD Type 1, noncytopathic BVD Type 2, Vibrio and the 5 most common strains of Lepto, including the U.S. strain of L. hardjo-bovis. For use in all classes of cattle, even pregnant cows and calves nursing pregnant cows. Features Xtend SP adjuvant.
Vira Shield® 6 + VL5 is a combination vaccine for use in vaccinating healthy breeding cattle as an aid in the prevention of disease caused by infectious bovine rhinotracheitis (IBR), cytopathic and non-cytopathic bovine virus diarrhea (BVD) Type 1, non-cytopathic bovine virus diarrhea (BVD) Type 2, parainfluenza Type 3 (PI3), bovine respiratory syncytial (BRSV) viruses, Campylobacter fetus and Leptospira canicola, grippotyphosa, hardjo, icterohaemorrhagiae, and pomona. Safe for heifers, pregnant cows, and calves nursing pregnant cows. Do not vaccinate animals within 60 days prior to slaughter. Needles and syringes sold separately.
- Shake well before using
- Administer 5 mL subcutaneously 2-4 weeks prior to breeding
- In accordance with Beef Quality Assurance guidelines, this product should be administered subcutaneously (under the skin) in the neck
- Revaccinate with Vira Shield® 6 in 4-5 weeks
- Revaccinate annually or as recommended by your veterinarian
For use in healthy breeding cattle, including pregnant cows and heifers, as an aid in the prevention of disease caused by infectious bovine rhinotracheitis (IBR), bovine virus diarrhea (BVD Type 1 and BVD Type 2), parainfluenza Type 3 (PI3), and bovine respiratory syncytial (BRSV) viruses and Campylobacter fetus, Leptospira canicola, grippotyphosa, hardjo-bovis, icterohaemorrhagiae, and pomona. For use in calves vaccinated at four weeks of age, or older, as an aid in the prevention of hardjo-bovis kidney colonization, and as an aid in preventing urinary shedding and reproductive tract infection for 12 months. Produced from non-cytopathic (BVD Type 1 and BVD Type 2) and cytopathic (BVD Type 1) isolates. Vaccinated animals subsequently exposed to L. borgpetersenii serovar hardjo (type hardjo-bovis) have been shown to clear renal infections within 8 weeks of exposure.
Store out of direct sunlight at 2°-8°C (35°-46°F). DO NOT FREEZE. Use entire contents when first opened. Do not mix with other products, except as specified on the label. In case of human exposure, contact a physician. Do not vaccinate within 60 days prior to slaughter. Transient swelling may occur at the site of injection. Milk reduction and transient depression may be observed in lactating dairy cows for 3-6 days following vaccination. Anaphylactic reactions may occur. Symptomatic treatment: Epinephrine. Contains amphotericin B, gentamicin, and thimerosal as preservatives.
Features of Vira Shield 6 Vl5
- Provides a 12 month DOI against L. hardjo-bovis
- Shown to deliver enhanced IBR fetal protection 8 months post-vaccination
- Can be given to entire herd, including pregnant cows and heifers, without complication
- Milk reduction may be observed in lactating dairy cows
Prices of Vira Shield 6 Vl5
$35.39 – $127.29